The role of systemic and targeted therapies in brain metastases

被引：5

作者：

Franceschi, Enrico ^{[1
]}

Bartolotti, Marco ^{[1
]}

Poggi, Rosalba ^{[1
]}

Di Battista, Monica ^{[1
]}

Palleschi, Dario ^{[1
]}

Brandes, Alba A. ^{[1
]}

机构：

[1] Azienda USL Bologna, Bellaria Maggiore Hosp, Dept Med Oncol, I-40139 Bologna, Italy

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2014年 / 14卷 / 01期

关键词：

BRAF V600E melanoma; brain metastases; EGFR mutations; HER2 breast cancer; target therapy; CELL LUNG-CANCER; LAPATINIB PLUS CAPECITABINE; PHASE-II TRIAL; TYROSINE KINASE INHIBITORS; EARLY BREAST-CANCER; RADIATION-THERAPY; OPEN-LABEL; INTRACRANIAL METASTASES; ADJUVANT TRASTUZUMAB; CEREBRAL METASTASES;

D O I：

10.1586/14737140.2014.856760

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

For many years, brain metastases (BMs) have been considered as the final stage of a disease course and engendered skepticism about the efficacy of treatments. Local treatments, mainly, whole-brain radiotherapy have been the standard of care, whereas chemotherapy has been considered of limited efficacy due to the potential role of blood-brain barrier.

引用

页码：93 / 103

页数：11

共 50 条

[21] The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases
Moraes, Fabio Ynoe
Taunk, Neil K.
Marta, Gustavo Nader
Suh, John H.
Yamada, Yoshiya
ONCOLOGIST, 2016, 21 (02): : 244 - 251
[22] Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies
Myall, Nathaniel J.
Yu, Helena
Soltys, Scott G.
Wakelee, Heather A.
Pollom, Erqi
NEURO-ONCOLOGY ADVANCES, 2021, 3 : V52 - V62
[23] Survival in melanoma brain metastases in the era of novel systemic therapies
Merola, Joseph P.
Ocen, Joanita
Kumar, Satish
Powell, James
Hayhurst, Caroline
NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
[24] Role of systemic therapy in the treatment of brain metastases
Dziadziuszko, R.
RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S282 - S283
[25] Targeted drugs for systemic therapy of lung cancer with brain metastases
Sun, Ya-Wen
Xu, Jian
Zhou, Jun
Liu, Wen-Juan
ONCOTARGET, 2018, 9 (04) : 5459 - 5472
[26] Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies
Khalifa, Jonathan
Amini, Arya
Popat, Sanjay
Gaspar, Laurie E.
Faivre-Finn, Corinne
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : 1627 - 1643
[27] Biology of brain metastases and novel targeted therapies: Time to translate the research
Fokas, Emmanouil
Steinbach, Joachim P.
Roedel, Claus
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1835 (01): : 61 - 75
[28] Avoiding Whole Brain Radiation Therapy for Brain Metastases in the Era of Targeted Therapies and Immunotherapy
Back, Michael
Or, Michelle
Jayamanne, Dasantha
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 75 - 75
[29] Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam, Sangeetha
Schadendorf, Dirk
Long, Georgina V.
CHINESE CLINICAL ONCOLOGY, 2015, 4 (02)
[30] Radiotherapy in combination with systemic therapies for brain metastases: current status and progress
Liu, Lei
Chen, Wanqi
Zhang, Ruopeng
Wang, Yuekun
Liu, Penghao
Lian, Xin
Zhang, Fuquan
Wang, Yu
Ma, Wenbin
CANCER BIOLOGY & MEDICINE, 2020, 17 (04) : 910 - 922

← 1 2 3 4 5 →